Francis McCormick
Fundador en BRIDGEBIO PHARMA, INC. .
Fortuna: 31 M $ al 31/05/2024
Perfil
Francis Patrick McCormick is the founder of BridgeBio Pharma LLC (founded in 2015), Onyx Pharmaceuticals, Inc. (founded in 1992), Avidity Biosciences, Inc. (founded in 2012), and BridgeBio Pharma, Inc. (founded in 2015).
He held the title of Chief Scientific Officer at Onyx Pharmaceuticals, Inc. from 1992 to 1996.
He is currently a Director at PellePharm, Inc., Arresto BioSciences, Inc., Melanoma Therapeutics Foundation, UCSF Helen Diller Family Comprehensive Cancer Center, Navire Pharma, Inc., and a Member of the National Academy of Sciences since 2014.
Dr. McCormick is also the founder of DNAtrix, Inc. He has held former positions as an Independent Director at Exelixis, Inc. from 2003 to 2014, Aduro BioTech, Inc. from 2010 to 2019, Olema Pharmaceuticals, Inc. from 2014 to 2021, and as Vice President-Research at Chiron Corp.
from 1991 to 1992.
He was also Vice President-Discovery Research at Cetus Corp.
from 1981 to 1992.
He served as President of the American Association for Cancer Research in 2013 and was an Associate Dean at UCSF School of Medicine from 1997 to 2014.
Dr. McCormick received a doctorate degree from the University of Cambridge in 1975 and an undergraduate degree from the University of Birmingham in 1972.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BRIDGEBIO PHARMA, INC.
0.59% | 01/04/2024 | 1 100 065 ( 0.59% ) | 31 M $ | 31/05/2024 |
Cargos activos de Francis McCormick
| Empresas | Cargo | Inicio |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Fundador | 01/01/2015 |
UCSF Helen Diller Family Comprehensive Cancer Center
 UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Director/Miembro de la Junta | 01/01/1997 |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | - |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | 01/01/2014 |
Melanoma Therapeutics Foundation
 Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Melanoma Therapeutics Foundation supports and researches treatments for melanoma. It provides resources for patients and physicians, supports investigators, and provides new drug development through bridging relationships between academia, pharmaceutical and biotechnology companies. The foundation is headquartered in San Francisco, California | Director/Miembro de la Junta | 28/06/2011 |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Director/Miembro de la Junta | 13/08/2009 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Fundador | 16/02/2010 |
Antiguos cargos conocidos de Francis McCormick.
| Empresas | Cargo | Fin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 05/04/2021 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Francis McCormick.
| University of Cambridge | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Empresas privadas | 14 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
PellePharm, Inc.
PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Health Technology |
| Cetus Corp. | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
Melanoma Therapeutics Foundation
Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Melanoma Therapeutics Foundation supports and researches treatments for melanoma. It provides resources for patients and physicians, supports investigators, and provides new drug development through bridging relationships between academia, pharmaceutical and biotechnology companies. The foundation is headquartered in San Francisco, California | Commercial Services |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Consumer Services |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |
Navire Pharma, Inc.
Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Francis McCormick
